Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07807644Phase 2Not yet recruiting
A Phase 2 trial of GRT7040 in acute pain, sponsored by Grünenthal GmbH. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07807644.